Skip to Content

GG 771 (Glipizide 5 mg)

Pill with imprint GG 771 is White, Round and has been identified as Glipizide 5 mg. It is supplied by Sandoz Pharmaceuticals Inc..

Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glipizide 5 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for GG 771

Glipizide 5 mg GG 771
Glipizide 5 mg GG 771  Front
Glipizide 5 mg GG 771  Back
Glipizide 5 mg GG 771  Front
Glipizide 5 mg GG 771  Back
Glipizide 5 mg GG 771

Glipizide

Imprint
GG 771
Strength
5 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Sulfonylureas
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Sandoz Pharmaceuticals Inc.
Inactive Ingredients
microcrystalline cellulose, croscarmellose sodium, lactose monohydrate, magnesium stearate, silicon dioxide, corn starch

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00781-1452 Sandoz Inc.
00904-6124 Major Pharmaceuticals
00832-0491 Upsher-Smith Laboratories Inc.
54569-3841 A-S Medication Solutions, LLC (repackager)
66267-0100 Nucare Pharmaceuticals Inc. (repackager)
67544-0302 Prepak Systems Inc. (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.